期刊文献+

评价社区老年2型糖尿病患者使用二甲双胍的治疗效果 被引量:2

To Evaluate the Efficacy of Metformin in the Treatment of Elderly Patients With Type 2 Diabetes Mellitus in Community
下载PDF
导出
摘要 目的评价社区老年2型糖尿病患者使用二甲双胍口服药物的治疗效果。方法选取我社区2013年1月~2015年1月收治的糖尿病患者258例,随机平均分为观察组与对照组。比较两组患者的血糖调整情况、血脂的改变情况、治疗后的不良反应情况。结果观察组的空腹血糖水平、餐后2 h血糖水平、糖化血红蛋白低于对照组,P〈0.05;观察组的总胆固醇、甘油三酯、高密度脂蛋白及低密度脂蛋白均低于对照组,P〈0.05;观察组的不良反应发病率为18.6%,低于对照组的49.6%,P〈0.05。结论社区老年2型糖尿病患者使用二甲双胍口服药治疗后可以有效改善血糖水平,效果明显,安全可靠。 Objective To evaluate the effect of oral administration of metformin in the treatment of elderly patients with type 2 diabetes mellitus in community. Methods 258 cases of diabetes in our community were selected from January 2013 to January 2015,and the average of the two groups were randomly divided into observation group and control group. Blood glucose regulation,blood lipid changes and adverse reactions after treatment were compared between the two groups. Results In observation group,fasting blood glucose,postprandial 2 h blood glucose and glycosylated hemoglobin levels lower than the control group,P〈0.05,the observation group total cholesterol,triglyceride and high density lipoprotein and low density lipoprotein were lower than the control group,P〈0.05,the incidence of adverse reactions of the observation group was 18.6%,lower than the control group 49.6%,P〈0.05. Conclusion Community elderly patients with type 2 diabetes using metformin oral drug treatment can effectively improve the blood glucose level,the effect is obvious,safe and reliable.
出处 《中国继续医学教育》 2016年第34期199-200,共2页 China Continuing Medical Education
关键词 2型糖尿病 社区 二甲双胍 Type 2 diabetes mellitus Community Metformin
  • 相关文献

参考文献8

二级参考文献47

  • 1于华众,李章平,吴朝明,程俊彦,陈寿权.二甲双胍致糖尿病乳酸性酸中毒10例分析[J].中国全科医学,2006,9(21):1811-1812. 被引量:16
  • 2陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 3Holman RR, Paul SK, Bethel MA, et al. 10-Year follow-up of intensive glucose control in type 2 diabetes[J]. N Engl J Med, 2008, 359(15) : 1577-1589.
  • 4Brown JB, Pedula K, Barzilay J, et al. Lactic acidosis rates in type 2 diabetes[J]. Diabetes Care, 1998, 21 (10) : 1659-1663.
  • 5Sirtori CR, Franceschini G, Galli-Kienle M, et al. Disposition of metformin (N, N-dimethylbiguanide) in man[J]. Clin Pharmacol Ther, 1978, 24 (6): 683-693.
  • 6Ong CR, Molyneaux LM, Constantino MI, et al. Long-term efficacy of metformin therapy in non-obese individuals with type 2 diabetes[J]. Diabetes Care, 2006, 29(11): 2361-2364.
  • 7Donnelly LA, Doney AS, Hattersley AT, et al. The effect of obesity on glycaemie response to metformin or sulphonylureas in type 2 diabetes[J]. Diabet Med, 2006, 23(2): 128-133.
  • 8UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J]. Lancet, 1998, 352 (9131) : 854-865.
  • 9Johnson JA, Majumdar SR, Simpson SH, et al, Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes[J]. Diabetes Care, 2002, 25 (12):2244-2248.
  • 10Danielle MH,Lawrence F.Patientage:a neglected factor when considering disease management in adults with type 2 diabetes[J].Patient Educ Couns,2011(85):154-159.

共引文献103

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部